Moreover, the up‐regulation of ENO3 in the liver may promote the progress of NASH by increasing GPX4 expression and the negative regulation of ferroptosis by lipid accumulation.43 This evidence concerns the gene ENO3 and metabolic dysfunction-associated steatohepatitis.